1.Psychometric Properties of the Heart Disease Knowledge Scale: Evidence from Item and Confirmatory Factor Analyses
Bee Chiu Lim ; Yee Cheng Kueh ; Wan Nor Arifin ; Kok Huan
Malaysian Journal of Medical Sciences 2016;23(4):33-45
Background: Heart disease knowledge is an important concept for health education, yet there is
lack of evidence on proper validated instruments used to measure levels of heart disease knowledge
in the Malaysian context.
Methods: A cross-sectional, survey design was conducted to examine the psychometric
properties of the adapted English version of the Heart Disease Knowledge Questionnaire (HDKQ).
Using proportionate cluster sampling, 788 undergraduate students at Universiti Sains Malaysia,
Malaysia, were recruited and completed the HDKQ. Item analysis and confirmatory factor analysis
(CFA) were used for the psychometric evaluation. Construct validity of the measurement model was
included.
Results: Most of the students were Malay (48%), female (71%), and from the field of science
(51%). An acceptable range was obtained with respect to both the difficulty and discrimination indices
in the item analysis results. The difficulty index ranged from 0.12.0.91 and a discrimination index of
. 0.20 were reported for the final retained 23 items. The final CFA model showed an adequate fit to
the data, yielding a 23-item, one-factor model [weighted least squares mean and variance adjusted
scaled chi-square difference = 1.22, degrees of freedom = 2, P-value = 0.544, the root mean square
error of approximation = 0.03 (90% confidence interval = 0.03, 0.04); close-fit P-value = > 0.950].
Conclusion: Adequate psychometric values were obtained for Malaysian undergraduate
university students using the 23-item, one-factor model of the adapted HDKQ.
2.A review of COVID-19 vaccination and the reported cardiac manifestations.
Jamie Sin Ying HO ; Ching-Hui SIA ; Jinghao Nicholas NGIAM ; Poay Huan LOH ; Nicholas Wen Sheng CHEW ; William Kok-Fai KONG ; Kian-Keong POH
Singapore medical journal 2023;64(9):543-549
In Singapore, 9.03 million doses of the mRNA COVID-19 vaccines by Pfizer-BioNTech and Moderna have been administered, and 4.46 million people are fully vaccinated. An additional 87,000 people have been vaccinated with vaccines in World Health Organization's Emergency Use Listing. The aim of this review is to explore the reported cardiac adverse events associated with different types of COVID-19 vaccines. A total of 42 studies that reported cardiac side effects after COVID-19 vaccination were included in this study. Reported COVID-19 vaccine-associated cardiac adverse events were mainly myocarditis and pericarditis, most commonly seen in adolescent and young adult male individuals after mRNA vaccination. Reports of other events such as acute myocardial infarction, arrhythmia and stress cardiomyopathy were rare. Outcomes of post-vaccine myocarditis and pericarditis were good. Given the good vaccine efficacy and the high number of cases of infection, hospitalisation and death that could potentially be prevented, COVID-19 vaccine remains of overall benefit, based on the current available data.
Adolescent
;
Humans
;
Male
;
Young Adult
;
COVID-19/prevention & control*
;
COVID-19 Vaccines/adverse effects*
;
Myocarditis/etiology*
;
Pericarditis
;
RNA, Messenger
;
Vaccination/adverse effects*